Donidalorsen Treatment in Children With Hereditary Angioedema

Clinical trial NCT07298447 · RECRUITING

Trial details

NCT number: NCT07298447
Sponsor: Ionis Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Hereditary Angioedema (HAE)

Start date: 2026-04-21
Primary completion: 2029-06-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.